Showing papers by "Franco Borzio published in 2018"

TL;DR: BCLC C stage does not identify patients homogeneous enough to be allocated to a single stage, and new patient‐tailored therapeutic indications are needed.

TL;DR: Survival prediction of HCC patients was very well done using TBS model, even stratifying the population in relation to the presence of metastases and/or vascular invasion, and its incorporation in a model composed by tumor- and liver function-related variables further increases its survival prediction.

TL;DR: Although the ITA.LI.CA score demonstrated the best prognostic performance at restaging, other variables should be considered to improve the prognostic assessment of patients at the time of deciding additional therapies for HCC.